diagnostic monopolies
diagnostic research domain
political economy of diagnostic innovation
comparative analysis
new generation of molecular diagnostic tests
new conceptual model of socio
comparative perspective Cancer screening
technical transition
diagnostics industry
public policy
new multi-scale
biomedicalisation
multi-level model of socio
comparative transnational analysis of regulatory decision-making
integrative analysis
socio-technical regime change
Human Genome Project
diagnostics sector
fields of research
paucity of research
age of diagnostics
early detection of cancer
regulatory developments
industry dynamics
private actors
private investments
qualitative methods
policy deliberation
genomic revolution
freight of expectations
post-genomic era
novel integration of conceptual insights
projectâ€™s innovative dimensions
technological trajectories
anecdote
literature
interactions
scholarship
broader programme of work
boundaries
USA
Europe
gene patenting
scientometric data
risks of under-
reconfiguring disease categories
expert opinion
empirical evidence
technologies
specific focus
factors
harms
unprecedented insight
health
over-regulation
platform of theory
decade
biomedicine
uncertainty
debate
present day
sickness